MSTH Connects: Psychoactive medication risk with young people and substance use

Join us on September 19, 2026 at 7amPT/9amCT/10amET for a webinar with Dr. Evan Wood. This presentation will focus on the current limitations of substance use care models and under-appreciated risks of certain psychoactive medications particularly for young people with substance use concerns.

Evan Wood, MD, PhD, FRCPC, FASAM, is a Professor of Medicine at the University of British Columbia. Dr. Wood has helped with the leadership of a number of clinical care and clinical training programs and as co-chaired the writing of a number of provincial and national substance use disorder therapeutic guidelines aimed at improving prevention and treatment of substance use disorders in primary care. This includes the 2023 national guideline for high risk drinking and alcohol use disorder which identified concerns with “polypharmacy” (i.e. multiple prescriptions) and how certain psychoactive medications may worsen substance use craving and outcomes from substance use disorder. His presentation will focus on the current limitations of substance use care models and under-appreciated risks of certain psychoactive medications particularly for young people with substance use concerns.